GPT Healthcare Reports 12.5% Revenue Growth in Q2 FY26, Signs MOU for New Hospital in Jamshedpur

2 min read     Updated on 14 Nov 2025, 08:59 AM
scanx
Reviewed by
Naman SharmaScanX News Team
Overview

GPT Healthcare Limited reported a 12.5% year-on-year revenue increase to INR 118.9 crores in Q2 FY26. EBITDA was INR 24.10 crores with a 20% margin, while PAT stood at INR 10.60 crores. The company signed an MOU for a new 150-bed hospital in Jamshedpur with an INR 70 crore investment. Operational improvements include reduced Average Length of Stay and increased Average Revenue Per Occupied Bed. The company aims to become a 1,000-bed hospital chain in the next two years, focusing on expansion in Tier 2 cities.

24636594

*this image is generated using AI for illustrative purposes only.

GPT Healthcare Limited , a prominent healthcare provider in Eastern India, has reported a 12.5% year-on-year increase in revenue for the second quarter of fiscal year 2026, reaching INR 118.9 crores. The company also announced plans for expansion, including signing a Memorandum of Understanding (MOU) for a new hospital in Jamshedpur.

Financial Highlights

  • Revenue from operations stood at INR 118.90 crores, up 12.5% year-on-year
  • EBITDA for Q2 FY26 was INR 24.10 crores, with a margin of 20%
  • Profit After Tax (PAT) came in at INR 10.60 crores, with a margin of 8.8%

The company's EBITDA saw a 10% year-on-year decrease, primarily due to initial losses of approximately INR 3 crores related to the new hospital in Raipur.

Operational Performance

GPT Healthcare has shown improvements in key operational metrics:

  • Average Length of Stay (ALOS) improved to 3.49 days as of September 30, 2025
  • Average Revenue Per Occupied Bed (ARPOB) stood at INR 38,376
  • Bed occupancy across the network was at 44.7%

Notably, about 92% of the company's business continues to come from cash and insurance patients, reflecting the strength of its neighborhood tertiary care model.

Hospital-wise Performance

Hospital Occupancy (Q2 FY26) ARPOB (INR) Key Highlights
ILS Raipur 12% 40,869 Started renal transplants, chemotherapy, and oncology surgeries
Salt Lake 64% 41,062 Over 700 robotic surgeries performed to date
Agartala 54% 35,000 Commenced comprehensive oncology services
Dum Dum 69% 42,000 Stable performance with revenues of INR 77 crores
Howrah 45% 34,900 Commenced robotic knee surgeries

Expansion Plans

GPT Healthcare has signed an MOU for a new 150-bed hospital in Jamshedpur, with an estimated investment of INR 70 crores. The facility is expected to be commissioned by the end of Q3 FY27, furthering the company's goal of becoming a 1,000-bed hospital chain over the next two years.

Future Outlook

The company expects:

  • Raipur hospital to achieve EBITDA breakeven in 12 to 15 months
  • An overall ARPOB growth of 5% to 6% through rate revisions and changes in case mix
  • EBITDA margins of around 20% to 21% for FY26, including initial losses from the Raipur hospital

Anurag Tantia, Executive Director of GPT Healthcare, stated, "We remain firmly committed to our goal of becoming a 1,000-bed hospital chain over the next two years. This target reflects our broader vision of scaling up operations and bringing quality healthcare to more communities, especially in the underserved regions of Eastern India."

GPT Healthcare continues to focus on expanding its presence in Tier 2 cities, exploring both acquisition and greenfield opportunities in locations such as Varanasi, Patna, and Cuttack.

As the company navigates challenges in new markets and works towards its expansion goals, it remains focused on delivering quality healthcare services and improving patient outcomes across Eastern India.

Historical Stock Returns for GPT Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.38%-3.48%-3.18%-10.00%-13.02%-28.93%
GPT Healthcare
View in Depthredirect
like16
dislike

GPT Healthcare Reports 9.8% Revenue Growth to Rs 228.92 Cr in H1FY26, Declares Interim Dividend

2 min read     Updated on 08 Nov 2025, 06:26 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
Overview

GPT Healthcare Limited reported a 9.8% year-on-year increase in total income to Rs 228.92 crore for H1FY26. Revenue from operations grew by 11% to Rs 226.00 crore. However, EBITDA margin compressed to 18.8% from 22.2%, and net profit declined by 26.2% to Rs 18.30 crore. The company commissioned a new 158-bed hospital in Raipur and aims to reach 1,000 beds within two years. An interim dividend of Re 1 per share was declared. Dr. Om Tantia was appointed as Chairman and Managing Director, while Mr. Shree Gopal Tantia became Vice Chairman.

24152167

*this image is generated using AI for illustrative purposes only.

GPT Healthcare Limited , a prominent healthcare provider in Eastern India, has reported a 9.8% year-on-year increase in total income for the first half of fiscal year 2026 (H1FY26). The company's financial results, released on November 8, 2025, showcase both growth and challenges in the healthcare sector.

Financial Highlights

  • Total income rose to Rs 228.92 crore in H1FY26, up from Rs 208.50 crore in H1FY25.
  • Revenue from operations grew by 11% to Rs 226.00 crore.
  • EBITDA margin compressed to 18.8% from 22.2% in the previous year.
  • Net profit declined by 26.2% to Rs 18.30 crore, compared to Rs 24.70 crore in H1FY25.

Operational Performance

GPT Healthcare operates a network of five multispecialty hospitals across Eastern India, with a total capacity of 719 beds. Key operational metrics for H1FY26 include:

Metric Value
Overall bed occupancy rate 44.7%
Average Revenue Per Occupied Bed (ARPOB) Rs 38,376
Average Length of Stay (ALOS) 3.49 days

Expansion and Strategic Initiatives

The company has been actively pursuing growth opportunities:

  • A new 158-bed hospital was commissioned in Raipur in May 2025.
  • GPT Healthcare aims to become a 1,000-bed facility within the next two years.
  • The expansion strategy focuses on Tier I and Tier II cities in Eastern India.

Dividend Declaration

The Board of Directors has declared an interim dividend of Re 1 per share for the financial year 2025-26. The record date for dividend eligibility is set for November 14, 2025, with payment expected on or before December 7, 2025.

Management Changes

In a significant leadership transition, the Board has approved the following appointments:

  • Dr. Om Tantia has been elevated to the position of Chairman and Managing Director.
  • Mr. Shree Gopal Tantia has been appointed as Vice Chairman of the company.

Both appointments are effective from November 8, 2025.

Financial Position

As of September 30, 2025, GPT Healthcare's balance sheet reflects:

  • Total assets of Rs 463.50 crore
  • Total equity of Rs 253.80 crore
  • Current ratio of approximately 1.03

Outlook

While GPT Healthcare has demonstrated revenue growth, the decline in profitability and EBITDA margin suggests challenges in cost management and operational efficiency. The company's expansion plans and strategic focus on Eastern India's underserved markets may provide opportunities for future growth, but careful execution will be crucial in improving financial performance.

Investors and stakeholders will likely monitor how the new leadership navigates these challenges and capitalizes on the company's expansion strategy in the coming quarters.

Historical Stock Returns for GPT Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.38%-3.48%-3.18%-10.00%-13.02%-28.93%
GPT Healthcare
View in Depthredirect
like19
dislike
More News on GPT Healthcare
Explore Other Articles
142.64
-0.54
(-0.38%)